| scholarly article | Q13442814 |
| P2093 | author name string | Leonid Gaidukov | |
| Arie Dagan | |||
| Shahar Rotem | |||
| Amram Mor | |||
| Fadia Zaknoon | |||
| Inna S Radzishevsky | |||
| P2860 | cites work | Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures | Q27627245 |
| Structure-based design of an indolicidin peptide analogue with increased protease stability | Q27642639 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells | Q28207583 | ||
| The increased bactericidal activity of a fatty acid-modified synthetic antimicrobial peptide of human cathepsin G correlates with its enhanced capacity to interact with model membranes. | Q52548777 | ||
| In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics. | Q54033317 | ||
| Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. | Q54526856 | ||
| Functional Synergism of the Magainins PGLa and Magainin-2 in Escherichia coli, Tumor Cells and Liposomes | Q57393932 | ||
| Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin | Q67997676 | ||
| The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa | Q72738395 | ||
| The NH2-terminal alpha-helical domain 1-18 of dermaseptin is responsible for antimicrobial activity | Q72739888 | ||
| Characterization of octapeptin-membrane interactions using spin-labeled octapeptin | Q72861258 | ||
| Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity | Q73413971 | ||
| Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations | Q73697723 | ||
| Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity | Q74038405 | ||
| Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues | Q74130341 | ||
| N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity | Q74595394 | ||
| Optimization of microbial specificity in cyclic peptides by modulation of hydrophobicity within a defined structural framework | Q77080008 | ||
| Bacteria-selective synergism between the antimicrobial peptides alpha-helical magainin 2 and cyclic beta-sheet tachyplesin I: toward cocktail therapy | Q77295809 | ||
| In vitro antibacterial properties of pexiganan, an analog of magainin | Q28343235 | ||
| Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111. | Q30032669 | ||
| Inhibitory action of a truncated derivative of the amphibian skin peptide dermaseptin s3 on Saccharomyces cerevisiae | Q32022060 | ||
| Antimicrobial peptides in mammalian and insect host defence | Q33536544 | ||
| Animal antimicrobial peptides: an overview | Q33638713 | ||
| Peptide-lipid interactions and mechanisms of antimicrobial peptides. | Q33725477 | ||
| Preservative agents in foods. Mode of action and microbial resistance mechanisms | Q33733598 | ||
| Diversity of antimicrobial peptides and their mechanisms of action | Q33789705 | ||
| Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents | Q34056228 | ||
| Antibacterial properties of dermaseptin S4 derivatives with in vivo activity | Q34113672 | ||
| Mechanisms of antimicrobial peptide action and resistance | Q34181099 | ||
| Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria | Q34487933 | ||
| Drosophila innate immunity: an evolutionary perspective | Q34507042 | ||
| Transgenic plants expressing cationic peptide chimeras exhibit broad-spectrum resistance to phytopathogens | Q34511736 | ||
| A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci | Q35124472 | ||
| Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. | Q35137651 | ||
| The lipophosphoglycan of Leishmania parasites | Q35534721 | ||
| Trichogin: a paradigm for lipopeptaibols. | Q35601457 | ||
| N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity | Q39470734 | ||
| N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide | Q39478158 | ||
| The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets | Q39570597 | ||
| Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli | Q39653098 | ||
| Cationic hydrophobic peptides with antimicrobial activity | Q39657941 | ||
| Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin | Q39779042 | ||
| An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression | Q40856439 | ||
| Role of the bactericidal/permeability-increasing protein in host defence. | Q41729809 | ||
| Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains | Q42130359 | ||
| Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations | Q42255683 | ||
| The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. | Q42282922 | ||
| A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids | Q43607748 | ||
| Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity | Q43883470 | ||
| Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture | Q43950631 | ||
| Direct comparison of membrane interactions of model peptides composed of only Leu and Lys residues | Q44415319 | ||
| Tolaasins A--E, five new lipodepsipeptides produced by Pseudomonas tolaasii | Q44912133 | ||
| Antimicrobial peptides are signaling molecules | Q46980434 | ||
| Analysis of Membrane-Binding Properties of Dermaseptin Analogues: Relationships between Binding and Cytotoxicity | Q47407242 | ||
| Dermaseptin, a peptide antibiotic, stimulates microbicidal activities of polymorphonuclear leukocytes | Q47906935 | ||
| Activity of dermaseptin K4-S4 against foodborne pathogens | Q47956641 | ||
| Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics | Q48010957 | ||
| Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. | Q52540321 | ||
| Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. | Q52545323 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antimicrobial peptide | Q1201508 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 2412-2420 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides | |
| P478 | volume | 49 |
| Q40205283 | A broad-spectrum bactericidal lipopeptide with anti-biofilm properties |
| Q33260522 | Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora |
| Q38863044 | Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability |
| Q42153121 | Antibacterial properties of an oligo-acyl-lysyl hexamer targeting Gram-negative species |
| Q42218485 | Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions |
| Q52655525 | Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? |
| Q35684711 | Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms |
| Q40169806 | Antiplasmodial activity of lauryl-lysine oligomers |
| Q40526949 | Bacterial capture by peptide-mimetic oligoacyllysine surfaces |
| Q37340150 | Comparison of facially amphiphilic versus segregated monomers in the design of antibacterial copolymers |
| Q43597969 | Consequences of N-acylation on structure and membrane binding properties of dermaseptin derivative K4-S4-(1-13). |
| Q39119349 | Covalent modification of a ten-residue cationic antimicrobial peptide with levofloxacin |
| Q64121324 | Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides |
| Q37968899 | Designing antimicrobial peptides: form follows function. |
| Q43758708 | Effect of dermaseptin on erythrocytes |
| Q42420922 | Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC-MS/MS. |
| Q41390340 | Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers |
| Q34250487 | Importance of residue 13 and the C-terminus for the structure and activity of the antimicrobial peptide aurein 2.2. |
| Q36137272 | In vivo biodistribution and small animal PET of (64)Cu-labeled antimicrobial peptoids |
| Q40107948 | Influence of Amphibian Antimicrobial Peptides and Short Lipopeptides on Bacterial Biofilms Formed on Contact Lenses. |
| Q42041041 | Mechanisms Mediating Bactericidal Properties and Conditions That Enhance the Potency of a Broad-Spectrum Oligo-Acyl-Lysyl |
| Q33866571 | Membrane binding of an acyl-lactoferricin B antimicrobial peptide from solid-state NMR experiments and molecular dynamics simulations |
| Q48310540 | Membrane negative curvature induced by a hybrid peptide from pediocin PA-1 and plantaricin 149 as revealed by atomistic molecular dynamics simulations |
| Q91809317 | Peptide/Peptoid Hybrid Oligomers: The Influence of Hydrophobicity and Relative Side-Chain Length on Antibacterial Activity and Cell Selectivity |
| Q41826503 | Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives |
| Q34896647 | R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro |
| Q45009581 | Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity |
| Q39792581 | Selective acylation enhances membrane charge sensitivity of the antimicrobial peptide mastoparan-x. |
| Q37875765 | Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action |
| Q37325942 | Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin. |
| Q52684130 | Synthesis and biological evaluation of novel aliphatic acid-conjugated antimicrobial peptides as potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability. |
| Q36904839 | Synthetic lipopeptides: a novel class of anti-infectives |
| Q97546978 | The value of antimicrobial peptides in the age of resistance |
| Q34763500 | Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli |
Search more.